Aroa Biosurgery Limited (ARX.AX)
AUD 0.41
(-4.71%)
AUD 0.41
(-4.71%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -9.78 Million AUD | -2666.19% |
| 2023 | -353.83 Thousand AUD | 94.93% |
| 2022 | -6.98 Million AUD | 56.79% |
| 2021 | -16.15 Million AUD | -471.8% |
| 2020 | -2.82 Million AUD | -1476.47% |
| 2019 | -179.25 Thousand AUD | 92.0% |
| 2018 | -2.23 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -11.44 Million AUD | -3135.16% |
| 2024 Q2 | -6.16 Million AUD | -134.89% |
| 2024 Q1 | -2.62 Million AUD | 1.56% |
| 2024 Q3 | -2.3 Million AUD | 62.6% |
| 2024 Q4 | -2.28 Million AUD | 1.09% |
| 2023 Q4 | -2.66 Million AUD | -198.11% |
| 2023 FY | -353.83 Thousand AUD | 94.93% |
| 2023 Q3 | -894.51 Thousand AUD | -71.45% |
| 2023 Q2 | -521.72 Thousand AUD | 0.0% |
| 2022 FY | -6.98 Million AUD | 56.79% |
| 2022 Q4 | -4.35 Million AUD | 0.0% |
| 2022 Q2 | -3.85 Million AUD | 0.0% |
| 2021 FY | -16.15 Million AUD | -471.8% |
| 2021 Q4 | -5.36 Million AUD | 0.0% |
| 2021 Q2 | -4.96 Million AUD | 0.0% |
| 2020 Q2 | 570.63 Thousand AUD | 0.0% |
| 2020 Q4 | -3.41 Million AUD | 0.0% |
| 2020 FY | -2.82 Million AUD | -1476.47% |
| 2019 FY | -179.25 Thousand AUD | 92.0% |
| 2018 FY | -2.23 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 65.002% |
| Adherium Limited | -11.98 Million AUD | 18.336% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -124.413% |
| Anteris Technologies Ltd | -66.63 Million AUD | 85.311% |
| Control Bionics Limited | -5.92 Million AUD | -65.075% |
| CardieX Limited | -4.63 Million AUD | -111.228% |
| Compumedics Limited | -269 Thousand AUD | -3538.552% |
| Cochlear Limited | 521.5 Million AUD | 101.877% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -103.319% |
| Cyclopharm Limited | -9.22 Million AUD | -6.104% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -506.272% |
| Nova Eye Medical Limited | -3.79 Million AUD | -157.775% |
| HeraMED Limited | -6.42 Million AUD | -52.267% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 44.31% |
| ImpediMed Limited | -19.03 Million AUD | 48.583% |
| InhaleRx Limited | -1.38 Million AUD | -605.936% |
| LBT Innovations Limited | -4.74 Million AUD | -106.492% |
| Micro-X Limited | -13.02 Million AUD | 24.866% |
| Neurotech International Limited | -5.58 Million AUD | -75.256% |
| OncoSil Medical Limited | -11.98 Million AUD | 18.328% |
| PolyNovo Limited | 1.16 Million AUD | 941.591% |
| Respiri Limited | -7 Million AUD | -39.82% |
| SomnoMed Limited | -3.84 Million AUD | -154.802% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 41.322% |
| Uscom Limited | -2.4 Million AUD | -307.083% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -67.193% |